Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Maintenance in Diffuse Pleural Mesothelioma
NCT07411144Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in pleural mesothelioma, sponsored by National Cancer Institute. Started Mar 2020; status: completed.
02
Drugs
gemcitabine
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on NCT07411144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07411144.